Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Finlay
versión On-line ISSN 2221-2434
Resumen
RAMOS RANGEL, Yamila et al. Therapeutic Adherence in Patients with Diabetes Mellitus Type 2. Rev. Finlay [online]. 2017, vol.7, n.2, pp. 89-98. ISSN 2221-2434.
Foundation: diabetes mellitus is a disease that has a growing and sustained impact on the health status of many nations. Objective: to estimate some relevant factors of therapeutic adherence in patients with diabetes mellitus type 2. Methods: a cross-sectional descriptive study was carried out in patients with diabetes mellitus type 2 belonging to the doctor’s office 3 of the Cartagena community during the period from October 2014 to May 2015. The variables analyzed were: sociodemographic: sex, age, educational level, occupation and marital status; about the disease: time of evolution, concomitant diseases, metabolic control; and the characteristics of the therapeutic regimen: modalities and dosage. The techniques used were: document analysis, history of the disease, current clinical status, indicated medical treatment and compliance, therapeutic adherence questionnaire and abbreviated questionnaire for the evaluation of therapeutic adherence in patients with diabetes mellitus type 2, clinical interview centered in the disease, characteristics of the therapeutic regime. The information was processed in the SPSS 15,0 statistical package for windows database. Descriptive statistics were used; the results were expressed in absolute and relative frequencies. Results: 63 % of patients with diabetes mellitus type 2 did not comply with the therapeutic recommendations; female representatives were the most treatment compliant (73 %), predominated as age range 51-60 years (82 %). The male gender was the most non-compliant in age ranges of 30-40 and 51-60 years, prevailing housewives prevailed (54.5 %). There was more behaviors adherent to the treatment in the first two years and after ten, with metabolic control (100 %), greater presence of concomitant diseases (82 %). Combined therapeutic regimen (96.7 %) and multidose (100 %) were similar in compliance and noncompliance. Conclusions: the need to take into account when explaining compliance behaviors in patients with chronic diseases such as type 2 diabetes mellitus, the diversity and complexity of factors influencing their dynamics which make interpretation difficult.
Palabras clave : diabetes mellitus type 2; medication adherence; chronic disease.